Recent investigations into the mechanism of SYK activation in AML have linked SYK to integrin beta signalling and the oncogenic transcription factors STAT3 and STAT5 [4, 5], providing a possible explanation for the clustered patterns that cells with high P-SYK activation exhibited under our IHC assay. Here, STAT3 is linked to acute myeloid leukemia.